Share
- Add this to...
- Favorites
- Del.icio.us
- Digg
- Facebook
- Google Bookmarks
- Yahoo MyWeb

U.S. Patient Survival Report

The U.S. Patient Survival Report displays an estimate of the number of patients who are alive after a bone marrow or umbilical cord blood transplant. The estimates are shown:

By disease and length of time after transplant: 100 days, 1 year, and 3 years
By the type of donor who provided the cells for transplant:
- Autologous (the patient's cells)
- Related allogeneic (a patient's sibling or another family member's cells)
- Unrelated allogeneic (a volunteer donor's cells)

The cells used for transplant can be from bone marrow, peripheral blood, or umbilical cord blood after a baby is born.

Choose the information for your report and then click Continue.
(To change a selection, use Previous Step.)

Step 1: Select a Disease

Reading This Report

Glossary
To learn how this report applies to your situation, talk with your doctor.

Transplant Data for This Report

Participating Transplant Centers
Data presented in this report show transplants performed from January 1, 2008 through December 31, 2010.
The Center for International Blood and Marrow Transplant Research^® maintains these data for the U.S. Health Resources and Services Administration as part of the Stem Cell Therapeutic Outcomes Database contract.
Citation Guidelines

Trends and More Data

View slides of transplant and outcomes data collected by the CIBMTR and information about transplants using only unrelated donors collected by the National Marrow Donor Program^® (NMDP).